AtriCure traded at $43.65 this Monday December 5th, decreasing $1.91 or 4.19 percent since the previous trading session. Looking back, over the last four weeks, AtriCure lost 8.04 percent. Over the last 12 months, its price fell by 35.42 percent. Looking ahead, we forecast AtriCure to be priced at 44.08 by the end of this quarter and at 39.94 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 378.22 1.02 0.27% 22.74%
Abbott 105.41 -2.68 -2.48% -20.43%
AtriCure 43.65 -1.91 -4.19% -35.42%
Baxter International 51.30 -1.92 -3.61% -35.26%
Becton, Dickinson and Co. 246.21 -6.17 -2.44% 0.03%
Boston Scientific 45.42 -1.18 -2.53% 11.60%
Cooper Companies 321.56 -0.76 -0.24% -19.60%
Artivion Inc 13.29 -0.24 -1.77% -28.01%
Cardiovascular Systems 13.65 -0.28 -2.01% -30.04%
Dexcom 116.56 -1.55 -1.31% -11.10%
Edwards Lifesciences 73.85 -2.70 -3.53% -34.04%
Globus Medical 72.28 -2.67 -3.56% 7.58%
Integra LifeSciences 55.67 -0.79 -1.40% -14.06%
Inogen 21.40 -1.60 -6.96% -32.36%
Intuitive Surgical 269.72 -2.53 -0.93% -16.69%
J&J 178.78 -0.10 -0.06% 9.72%
Masimo 142.55 -2.95 -2.03% -49.18%
Medtronic 78.79 -0.83 -1.04% -28.53%
Merit Medical Systems 71.11 -1.93 -2.64% 8.48%
NuVasive 39.63 -0.34 -0.85% -23.17%
Insulet 302.43 -5.63 -1.83% 16.71%
ResMed 219.35 -13.55 -5.82% -15.73%
Stryker 237.90 -5.21 -2.14% -6.49%
Teleflex 235.78 -6.80 -2.80% -26.42%
Tandem Diabetes Care 42.44 -0.31 -0.73% -67.61%
Zimmer Biomet Holdings Inc 122.28 -0.69 -0.56% -2.56%

Indexes Price Day Year
USND 11240 -221.56 -1.93% -26.18%
US2000 1840 -52.62 -2.78% -16.49%

AtriCure
AtriCure, Inc. is a provider of technologies for the treatment of atrial fibrillation (Afib) and related conditions. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage, and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers globally. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation includes Isolator Synergy Clamp and Multifunctional Pens and Linear Ablation Devices. Its Product for open ablation are cryoICE Cryoablation System. Its product for minimally invasive ablation are EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management includes AtriClip System and LARIAT System.